Van ECK Associates Corp Purchases 13,592 Shares of Healthcare Realty Trust Incorporated (NYSE:HR)

Van ECK Associates Corp lifted its holdings in Healthcare Realty Trust Incorporated (NYSE:HR) by 8.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 166,676 shares of the real estate investment trust’s stock after buying an additional 13,592 shares during the quarter. Van ECK Associates Corp’s holdings in Healthcare Realty Trust were worth $3,040,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Allspring Global Investments Holdings LLC boosted its stake in Healthcare Realty Trust by 38.1% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,276 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 628 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Healthcare Realty Trust by 260.6% in the second quarter. EverSource Wealth Advisors LLC now owns 2,809 shares of the real estate investment trust’s stock worth $50,000 after buying an additional 2,030 shares in the last quarter. Harbor Capital Advisors Inc. bought a new position in shares of Healthcare Realty Trust in the third quarter worth approximately $89,000. GAMMA Investing LLC grew its holdings in shares of Healthcare Realty Trust by 67.2% during the second quarter. GAMMA Investing LLC now owns 5,569 shares of the real estate investment trust’s stock valued at $92,000 after buying an additional 2,238 shares during the last quarter. Finally, Virtu Financial LLC bought a new stake in shares of Healthcare Realty Trust during the first quarter valued at approximately $152,000.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Wells Fargo & Company reaffirmed an “underweight” rating and issued a $17.00 price objective (up from $16.00) on shares of Healthcare Realty Trust in a research report on Tuesday, October 1st. Wedbush increased their price objective on Healthcare Realty Trust from $15.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Scotiabank boosted their target price on Healthcare Realty Trust from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $17.17.

Healthcare Realty Trust Price Performance

HR stock opened at $17.78 on Friday. Healthcare Realty Trust Incorporated has a 1 year low of $12.77 and a 1 year high of $18.90. The company has a market cap of $6.30 billion, a P/E ratio of -11.25 and a beta of 0.91. The stock’s fifty day moving average price is $17.85 and its 200-day moving average price is $17.05.

Healthcare Realty Trust Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Tuesday, November 12th will be paid a dividend of $0.31 per share. The ex-dividend date is Tuesday, November 12th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 6.97%. Healthcare Realty Trust’s dividend payout ratio is currently -78.48%.

Insider Activity

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian purchased 9,000 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were acquired at an average price of $17.39 per share, for a total transaction of $156,510.00. Following the purchase, the director now directly owns 22,252 shares of the company’s stock, valued at $386,962.28. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Healthcare Realty Trust news, Director John Knox Singleton purchased 6,500 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were bought at an average price of $18.24 per share, with a total value of $118,560.00. Following the completion of the purchase, the director now directly owns 57,082 shares in the company, valued at $1,041,175.68. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Thomas N. Bohjalian bought 9,000 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were acquired at an average price of $17.39 per share, for a total transaction of $156,510.00. Following the completion of the transaction, the director now directly owns 22,252 shares in the company, valued at approximately $386,962.28. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired 15,728 shares of company stock valued at $279,069 in the last quarter. 0.56% of the stock is currently owned by insiders.

About Healthcare Realty Trust

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.